Healthcare >> CEO Interviews >> October 5, 2000
WILLIAM D. YOUNG joined ViroLogic, Inc., as Chairman of the Board
and CEO in November 1999. From 1980 until joining ViroLogic, he
was employed at Genentech, Inc., most recently as Chief Operating
Officer. As COO, Mr. Young was responsible for all of the
company's development, operations and commercial functions. Prior
to joining Genentech, he worked at Eli Lilly and Company for 14
years and held various positions in process engineering,
antibiotic process development and production management. He
received his Bachelor's degree in Chemical Engineering from
Purdue University and his Master's of Business Administration
from Indiana University. In 1993 he was elected to membership in
the National Academy of Engineering division of the National
Academy of Sciences for his contributions to the development of
manufacturing technology for biotechnology-based drug products
and in 2000 was awarded an Honorary Doctorate of Engineering by
Purdue University. Mr. Young is a member of the Board of
Directors of IDEC Pharmaceuticals as well as several private
biotechnology companies. Profile
Inc.?
Mr. Young: ViroLogic is about four and half years old. It was founded to
address what has become a growing crisis
